190.02
price up icon8.54%   14.95
pre-market  시장 영업 전:  188.98   -1.04   -0.55%
loading
전일 마감가:
$175.07
열려 있는:
$178.88
하루 거래량:
1.67M
Relative Volume:
2.21
시가총액:
$4.00B
수익:
$1.77M
순이익/손실:
$-123.74M
주가수익비율:
-20.72
EPS:
-9.17
순현금흐름:
$-95.21M
1주 성능:
+261.81%
1개월 성능:
+350.07%
6개월 성능:
+437.69%
1년 성능:
+159.84%
1일 변동 폭
Value
$176.61
$191.91
1주일 범위
Value
$52.62
$205.89
52주 변동 폭
Value
$26.70
$205.89

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name
명칭
Praxis Precision Medicines Inc
Name
전화
617-300-8460
Name
주소
99 HIGH STREET, 30TH FLOOR, BOSTON
Name
직원
82
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
PRAX's Discussions on Twitter

PRAX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PRAX
Praxis Precision Medicines Inc
190.02 3.69B 1.77M -123.74M -95.21M -9.17
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.27 107.45B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
474.00 64.39B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
579.34 61.13B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
834.75 52.30B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.31 35.49B 398.11M -1.03B -868.57M -5.7032

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-02 재개 Oppenheimer Outperform
2025-05-07 개시 Chardan Capital Markets Buy
2025-03-03 재확인 H.C. Wainwright Buy
2025-02-11 개시 Deutsche Bank Buy
2024-08-05 개시 Oppenheimer Outperform
2024-06-24 개시 Needham Buy
2024-06-18 개시 Guggenheim Buy
2024-05-01 개시 Robert W. Baird Outperform
2023-09-19 개시 Truist Buy
2022-06-06 다운그레이드 Wedbush Outperform → Neutral
2021-12-16 개시 H.C. Wainwright Buy
2021-08-26 개시 BofA Securities Buy
2021-04-26 개시 William Blair Outperform
2020-11-11 개시 Wedbush Outperform
2020-11-10 개시 Cowen Outperform
2020-11-10 개시 Evercore ISI Outperform
2020-11-10 개시 Piper Sandler Overweight
모두보기

Praxis Precision Medicines Inc 주식(PRAX)의 최신 뉴스

pulisher
Oct 21, 2025

Does Praxis Precision Medicines Inc. qualify in momentum factor screening2025 Volume Leaders & Weekly Return Optimization Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

What institutional flow reveals about Praxis Precision Medicines Inc.Market Movement Recap & Community Driven Trade Alerts - newser.com

Oct 21, 2025
pulisher
Oct 21, 2025

Rapid Rise of PRAX: Essential Tremor Breakthrough - StocksToTrade

Oct 21, 2025
pulisher
Oct 21, 2025

Praxis Precision Medicines, Inc. Announces FDA Type B Meeting for Ulixacaltamide - TradingView

Oct 21, 2025
pulisher
Oct 21, 2025

12 Reddit Stocks That Will Go to the Moon - Insider Monkey

Oct 21, 2025
pulisher
Oct 21, 2025

Applying big data sentiment scoring on Praxis Precision Medicines Inc.Stop Loss & Verified Stock Trade Ideas - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Wedbush Maintains Praxis Precision Medicines (PRAX) Underperform Recommendation - Nasdaq

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 08:35:46 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Wedbush lifts Praxis Precision Medicines PT; shares down - TradingView

Oct 20, 2025
pulisher
Oct 20, 2025

Largest borrow rate increases among liquid names - TipRanks

Oct 20, 2025
pulisher
Oct 20, 2025

Published on: 2025-10-20 07:35:45 - newser.com

Oct 20, 2025
pulisher
Oct 20, 2025

Wedbush Boosts Price Target on Praxis Precision Medicines to $73 From $33, Keeps Underperform Rating - MarketScreener

Oct 20, 2025
pulisher
Oct 20, 2025

Praxis Precision Medicines Announces Underwritten Offering - TradingView

Oct 20, 2025
pulisher
Oct 19, 2025

Praxis surges after late-stage trial success for movement disorder therapy - MSN

Oct 19, 2025
pulisher
Oct 19, 2025

Praxis Precision’s tremor-drug trial succeeds where others have failed. The stock is skyrocketing. - MSN

Oct 19, 2025
pulisher
Oct 18, 2025

Is Praxis Precision Medicines Inc. stock undervalued vs historical averagesPortfolio Return Summary & Safe Capital Growth Trade Ideas - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 18, 2025

Praxis Precision Medicines (PRAX) Is Up 256.7% After Positive Phase 3 Results for Essential Tremor Drug - simplywall.st

Oct 18, 2025
pulisher
Oct 18, 2025

Is Praxis Precision Medicines Inc. stock a buy on dipsJuly 2025 Fed Impact & Verified Stock Trade Ideas - nchmf.gov.vn

Oct 18, 2025
pulisher
Oct 17, 2025

Major Investment Alert: Adage Capital’s Bold Move in Praxis Precision Medicines! - TipRanks

Oct 17, 2025
pulisher
Oct 17, 2025

Is Praxis Precision Medicines Inc. stock cheap at current valuationJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - nchmf.gov.vn

Oct 17, 2025
pulisher
Oct 17, 2025

PRAX underwritten deal: $157/share, warrants; $567M net proceeds - Stock Titan

Oct 17, 2025
pulisher
Oct 17, 2025

PRAX prices common stock and pre-funded warrants; proceeds ~$493.0M - Stock Titan

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines, Inc.Common Stock (NQ: PRAX - FinancialContent

Oct 17, 2025
pulisher
Oct 17, 2025

Can Praxis Precision Medicines Keep Climbing? - timothysykes.com

Oct 17, 2025
pulisher
Oct 17, 2025

[Form 4] Praxis Precision Medicines, Inc. Insider Trading Activity - Stock Titan

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Shares Skyrocket: Too Late to Buy? - StocksToTrade

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines: A New High? - timothysykes.com

Oct 17, 2025
pulisher
Oct 17, 2025

Revolution Medicines, Disc Medicine, American Express And Other Big Stocks Moving Higher On Friday - Benzinga

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision (PRAX) Triples on Stellar Drug Trial Results - Insider Monkey

Oct 17, 2025
pulisher
Oct 17, 2025

Ulixacaltamide Trial Success Propels PRAX - StocksToTrade

Oct 17, 2025
pulisher
Oct 17, 2025

Boston biotech raises $525M after stock triples on late-stage drug trial results - The Business Journals

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines (PRAX) Surges 183.7%: Is This an Indication of Further Gains? - Yahoo Finance

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines (PRAX) Stock Soars After Essential Tremor Drug Success - parameter.io

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines, Inc. (PRAX) Stock: Soars 183% Following $525M Public Offering Announcement - parameter.io

Oct 17, 2025
pulisher
Oct 17, 2025

HC Wainwright & Co. Maintains Praxis Precision Medicines (PRAX) Buy Recommendation - Nasdaq

Oct 17, 2025
pulisher
Oct 17, 2025

Deutsche Bank Boosts Price Target on Praxis Precision Medicines to $280 From $65, Keeps Buy Rating - MarketScreener

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines extends rally after $525 mln stock sale - TradingView

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis: Back From The Dead, Ulixacaltamide Returns In Essential Tremor With Caveats (PRAX) - Seeking Alpha

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines Reaches Analyst Target Price - Nasdaq

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines prices $525 million public offering By Investing.com - Investing.com Nigeria

Oct 17, 2025
pulisher
Oct 17, 2025

Why Praxis Precision Medicines Stock Skyrocketed - TipRanks

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Stock Extends Rally Premarket As Wall Street Turns Hyper-Bullish After Essential Tremor Trial Win - Stocktwits

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines Prices $525 Million Share Offering - MarketScreener

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines prices $525 million public offering - Investing.com India

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines (PRAX) Aims to Raise $525M Through Pu - GuruFocus

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines prices $525M public offering - MSN

Oct 17, 2025
pulisher
Oct 17, 2025

A Look at Praxis Precision Medicines (PRAX) Valuation Following Positive Phase 3 Results in Essential Tremor - simplywall.st

Oct 17, 2025
pulisher
Oct 17, 2025

Praxis Precision Medicines, Inc. Announces Pricing of $525 Million Public Offering - Investing News Network

Oct 17, 2025
pulisher
Oct 16, 2025

Praxis Precision Medicines Announces Pricing of $525 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative

Oct 16, 2025
pulisher
Oct 16, 2025

$525M Offering — Praxis Precision Medicines Prices Common Stock at $157 per Share - Stock Titan

Oct 16, 2025
pulisher
Oct 16, 2025

Praxis Precision Medicines stock soars as Oppenheimer raises price target on trial success - Investing.com Philippines

Oct 16, 2025

Praxis Precision Medicines Inc (PRAX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$37.48
price up icon 2.32%
$87.30
price up icon 1.31%
$30.13
price down icon 1.34%
$106.89
price down icon 0.98%
biotechnology ONC
$315.74
price down icon 0.90%
$165.31
price down icon 1.55%
자본화:     |  볼륨(24시간):